Pharmafile Logo
Pharmafocus logo
Advanced Search

Oxford Nanopore Technologies

Showing 1 posts of 1 posts found.

Novo Holdings Invests in Oxford Nanopore Technologies 

August 1, 2024
Research and Development Microbiology, Novo Holdings, Oxford Nanopore Technologies, biopharmacuticals, biotech, data, drug therapies, investment

leading life science investor Novo Holdings, announced a £50m investment in Oxford Nanopore Technologies. Oxford Nanopore Technologies is a leading …

News
The Gateway to Local Adoption Series

Latest content

Long-acting therapies set to reshape HIV treatment market

August 21, 2026

MHRA authorises Lynkuet for hot flushes linked to breast cancer therapy

August 21, 2026

MHRA approves Romvimza for tenosynovial giant cell tumour

August 20, 2026

NICE recommends allergy immunotherapy tablets for younger children

August 19, 2026

Dunbar Pharmaceuticals and IPS Pharma announce distribution agreement

August 18, 2026